IMMUNIC INC
COM · CUSIP 4525EP101
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 68 |
| Q4 2022 | 63 |
| Q1 2023 | 63 |
| Q2 2023 | 66 |
| Q3 2023 | 55 |
| Q4 2023 | 51 |
| Q1 2024 | 62 |
| Q2 2024 | 58 |
| Q3 2024 | 63 |
| Q4 2024 | 68 |
| Q1 2025 | 66 |
| Q2 2025 | 57 |
| Q3 2025 | 61 |
| Q4 2025 | 60 |
| Q1 2026 | 75 |
| Q2 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 28 | 19 |
| Q4 2024 | 30 | 22 |
| Q1 2025 | 23 | 32 |
| Q2 2025 | 20 | 28 |
| Q3 2025 | 24 | 18 |
| Q4 2025 | 24 | 18 |
| Q1 2026 | 50 | 23 |
| Q2 2026 | 0 | 74 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $582.0k | $55.4k | 0.10 |
| Q4 2025 | $255.7k | $21.7k | 0.08 |
| Q1 2026 | $526.5k | $81.0k | 0.15 |
| Q2 2026 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Aberdeen Group plc | Sold out | -8.2m |
| BVF INC/IL | Sold out | -7.7m |
| Avidity Partners Management LP | Sold out | -7.4m |
| VANGUARD CAPITAL MANAGEMENT LLC | Sold out | -5.1m |
| Soleus Capital Management, L.P. | Sold out | -4.5m |
| Laurion Capital Management LP | Sold out | -3.9m |
| MILLENNIUM MANAGEMENT LLC | Sold out | -3.8m |
| MORGAN STANLEY | Sold out | -3.3m |
| Nantahala Capital Management, LLC | Sold out | -2.5m |
| 683 Capital Management, LLC | Sold out | -2.5m |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BIOTECHNOLOGY VALUE FUND L P
13D · may seek influence
no change · filed 2026-02-20
Stated purposeThe Reporting Persons purchased the securities reported owned herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. Securities Purchase Agreement On February 12, 2026, the Issuer and certain accredited in… Full filing |
10.0% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor new · filed 2026-02-20 | 10.0% |
| JANUS HENDERSON GROUP PLC 13G · institution +7.0 pts · filed 2025-12-08 | 10.0% |
| Adage Capital Management, L.P. 13G · institution +8.4 pts · filed 2025-08-12 | 10.0% |
| Avidity Partners Management LP 13G · passive investor +5.1 pts · filed 2026-04-17 | 9.9% |
| Commodore Capital LP 13G · passive investor new · filed 2026-02-24 | 9.9% |
| Trails Edge Capital Partners, LP 13G · passive investor new · filed 2026-02-24 | 8.7% |
| Deep Track Capital, LP 13G · passive investor new · filed 2026-03-04 | 8.7% |
| Nantahala Capital Management, LLC 13G · institution -1.8 pts · filed 2026-02-13 | 8.2% |
| Aberdeen Group plc 13G · institution -1.8 pts · filed 2026-02-02 | 6.8% |
| 683 Capital Management, LLC 13G · passive investor -4.0 pts · filed 2026-02-17 | 5.9% |
| Soleus Capital Master Fund, L.P. 13G · passive investor new · filed 2026-02-19 | 5.5% |
| ORBIMED ADVISORS LLC 13G · passive investor new · filed 2026-08-14 | 5.3% |
Fell to 5% or below in the last year: Alyeska Investment Group, L.P. (4.8%, 2026-05-15), ARMISTICE CAPITAL, LLC (5.0%, 2025-11-14)
Holders, Q2 2026
| Manager | Shares | Change |
|---|